Chronic Myeloid Leukemia Treatments

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

Frequent deletions and down-regulation of micro- RNA genes <i>miR15</i> and <i>miR16</i> at 13q14 in chronic lymphocytic leukemia

Genomic Classification and Prognosis in Acute Myeloid Leukemia

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Acute Myeloid Leukemia

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia

Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

Clinical staging of chronic lymphocytic leukemia

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

Estimating causal effects of treatments in randomized and nonrandomized studies.

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Myeloid-derived suppressor cells as regulators of the immune system.